Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 3
2002 5
2003 5
2004 4
2005 4
2006 4
2007 8
2008 2
2009 5
2010 11
2011 11
2012 8
2013 9
2014 7
2015 3
2016 8
2017 8
2018 7
2019 5
2021 1
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 24668647

107 results

Results by year

Filters applied: . Clear all
Page 1
Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patients.
Occhipinti S, Sponton L, Rolla S, Caorsi C, Novarino A, Donadio M, Bustreo S, Satolli MA, Pecchioni C, Marchini C, Amici A, Cavallo F, Cappello P, Pierobon D, Novelli F, Giovarelli M. Occhipinti S, et al. Clin Cancer Res. 2014 Jun 1;20(11):2910-21. doi: 10.1158/1078-0432.CCR-13-2663. Epub 2014 Mar 25. Clin Cancer Res. 2014. PMID: 24668647 Free article.
A tat fusion protein-based tumor vaccine for breast cancer.
Viehl CT, Becker-Hapak M, Lewis JS, Tanaka Y, Liyanage UK, Linehan DC, Eberlein TJ, Goedegebuure PS. Viehl CT, et al. Ann Surg Oncol. 2005 Jul;12(7):517-25. doi: 10.1245/ASO.2005.06.028. Epub 2005 May 10. Ann Surg Oncol. 2005. PMID: 15889213
Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice.
Wang L, Xie Y, Ahmed KA, Ahmed S, Sami A, Chibbar R, Xu Q, Kane SE, Hao S, Mulligan SJ, Xiang J. Wang L, et al. Breast Cancer Res Treat. 2013 Jul;140(2):273-84. doi: 10.1007/s10549-013-2626-7. Epub 2013 Jul 24. Breast Cancer Res Treat. 2013. PMID: 23881522
[Anti-HER2 vaccines: The HER2 immunotargeting future?].
Ladjemi MZ, Jacot W, Pèlegrin A, Navarro-Teulon I. Ladjemi MZ, et al. Pathol Biol (Paris). 2011 Jun;59(3):173-82. doi: 10.1016/j.patbio.2009.04.002. Epub 2009 May 28. Pathol Biol (Paris). 2011. PMID: 19481373 Free article. Review. French.
107 results